Uncovering the "riddle of femininity" in osteoarthritis: a systematic review and meta-analysis of menopausal animal models and mathematical modeling of estrogen treatment.

OBJECTIVE: Post-menopausal women are disproportionately affected by osteoarthritis (OA). As such, the purpose of this study was to (1) summarize the state-of-the-science aimed at understanding the effects of menopause on OA in animal models and (2) investigate how dosage and timing of initiation of estrogen treatment affect cartilage degeneration. DESIGN: A systematic review identified articles studying menopausal effects on cartilage in preclinical models. A meta-analysis was performed using overlapping cartilage outcomes in conjunction with a rigor and reproducibility analysis. Ordinary differential equation models were used to determine if a relationship exists between cartilage degeneration and the timing of initiation or dosage of estrogen treatment. RESULTS: Thirty-eight manuscripts were eligible for inclusion. The most common menopause model used was ovariectomy (92%), and most animals were young at the time of menopause induction (86%). Most studies did not report inclusion criteria, animal monitoring, protocol registration, or data accessibility. Cartilage outcomes were worse in post-menopausal animals compared to age-matched, non-menopausal animals, as evidenced by cartilage histological scoring [0.75, 1.72], cartilage thickness [-4.96, -0.96], type II collagen [-4.87, -0.56], and c-terminal cross-linked telopeptide of type II collagen (CTX-II) [2.43, 5.79] (95% CI of Effect Size (+greater in menopause, -greater in non-menopause)). Moreover, modeling suggests that cartilage health may be improved with early initiation and higher doses of estrogen treatment. CONCLUSIONS: To improve translatability, animal models that consider aging and natural menopause should be utilized, and more attention to rigor and reproducibility is needed. Timing of initiation and dosage may be important factors modulating therapeutic effects of estrogen on cartilage.

Effects of ascorbic acid concentration on the tissue engineering of the temporomandibular joint disc.

The temporomandibular joint (TMJ) disc is a specialized fibrocartilaginous tissue. When the disc becomes an obstacle and becomes damaged, surgeons have no choice but to perform a discectomy. Tissue engineering may provide a novel treatment modality for TMJ disorder patients who undergo discectomy. No studies have been conducted on the most favourable media for TMJ disc cells. The objective of the current study was to examine the effects on biochemical and biomechanical properties of varying ascorbic acid concentrations (0, 25, or 50 microg/ml) on TMJ disc cells seeded on non-woven PGA scaffolds. The ascorbic acid concentration of the 25 microg/ml group resulted in more effective cell seeding of the scaffolds, with 1.53 million cells per construct, by comparison with the 0 and 50 microg/ml groups which had 1.20 million and 1.32 million cells per scaffold respectively. At week 4, the 25 microg/ml group had a higher collagen content than the 0 microg/ml group, with 30.4 +/- 2.7 and 24.9 +/- 3.3 microg of collagen per construct respectively. The 25 microg/ml group had a higher aggregate modulus than the 50 microg/ml group, with values of 6.1 +/- 1.3 and 4.0 +/- 0.9 kPa respectively at week 4. The results of this study indicate that the use of 25 microg/ml of ascorbic acid in culture media is effective for the tissue engineering of the TMJ disc, significantly outperforming media without or with 50 microg/ml of ascorbic acid.

Biochemical analysis of the porcine temporomandibular joint disc.

Tissue engineering can be a boon in treating lesions of the disc in the temporomandibular joint (TMJ). Unfortunately, little is known about its biochemical content, so we analysed the discs of six slaughtered pigs. We measured the content and distribution of total DNA, glycosaminoglycan, and collagen. The mean (S.D.) content of DNA was 0.14% (0.08%) of the dry weight, of glycosaminoglycan 0.96% (0.39%), and of collagen 68.2% (14.5%). There were no significant differences from top to bottom, but from front to back the smallest concentration of glycosaminoglycan was in the posterior band, and the highest concentration of collagen was in the intermediate zone. The concentrations of DNA and glycosaminoglycan were higher in the medial than in the lateral area of the disc.

A new oxoanion: [IO]3- containing I(V) with a stereochemically active lone-pair in the silver uranyl iodate tetraoxoiodate(V), Ag4(UO2)4(IO3)2(IO4)2O2 .

The hydrothermal reaction of elemental Ag, or water-soluble silver sources, with UO3 and I2O5 at 200 degrees C for 5 days yields Ag4(UO2)4(IO3)2(IO4)2O2 in the form of orange fibrous needles. Single-crystal X-ray diffraction studies on this compound reveal a highly complex network structure consisting of three interconnected low-dimensional substructures. The first of these substructures are ribbons of UO8 hexagonal bipyramids that edge-share to form one-dimensional chains. These units further edge-share with pentagonal bipyramidal UO7 units to create ribbons. The edges of the ribbons are partially terminated by tetraoxoiodate(V), [IO4]3-, anions. The uranium oxide ribbons are joined by bridging iodate ligands to yield two-dimensional undulating sheets. These sheets help to form, and are linked together by, one-dimensional chains of edge-sharing AgO7 capped octahedral units and ribbons formed by corner-sharing capped trigonal planar AgO4 polyhedra, AgO6 capped square pyramids, and AgO6 octahedra. The [IO4]3- anions in Ag4(UO2)4(IO3)2)(IO4)2O2 are tetraoxoiodate(V), not metaperiodate, and contain I(V) with a stereochemically active lone-pair. Bond valence sum calculations are consistent with this formulation. Differential scanning calorimetry measurements show distinctly different thermal behavior of Ag4(UO2)4(IO3)2(IO4)2O2 versus other uranyl iodate compounds with endotherms at 479 and 494 degrees C. Density functional theory (DFT) calculations demonstrate that the approximate C2v geometry of the [IO4]3- anion can be attributed to a second-order Jahn-Teller distortion. DFT optimized geometry for the [IO4]3- anion is in good agreement with those measured from single-crystal X-ray diffraction studies on Ag4(UO2)4(IO3)2(IO4)2O2.

Excision of uranium oxide chains and ribbons in the novel one-dimensional uranyl iodates K(2)[(UO(2))3(IO(3))(4)O(2)] and Ba[(UO(2)2(IO(3))(2)O(2)](H(2)O).

The alkali metal and alkaline-earth metal uranyl iodates K(2)[(UO(2))(3)(IO(3))(4)O(2)] and Ba[(UO(2))(2)(IO(3))(2)O(2)](H(2)O) have been prepared from the hydrothermal reactions of KCl or BaCl(2) with UO(3) and I(2)O(5) at 425 and 180 degrees C, respectively. While K(2)[(UO(2))(3)(IO(3))(4)O(2)] can be synthesized under both mild and supercritical conditions, the yield increases from <5% to 73% as the temperature is raised from 180 to 425 degrees C. Ba[(UO(2))(2)(IO(3))(2)O(2)](H(2)O), however, has only been isolated from reactions performed in the mild temperature regime. Thermal measurements (DSC) indicate that K(2)[(UO(2))(3)(IO(3))(4)O(2)] is more stable than Ba[(UO(2))(2)(IO(3))(2)O(2)](H(2)O) and that both compounds decompose through thermal disproportionation at 579 and 575 degrees C, respectively. The difference in the thermal behavior of these compounds provides a basis for the divergence of their preparation temperatures. The structure of K(2)[(UO(2))(3)(IO(3))(4)O(2)] is composed of [(UO(2))(3)(IO(3))(4)O(2)](2)(-) chains built from the edge-sharing UO(7) pentagonal bipyramids and UO(6) octahedra. Ba[(UO(2))(2)(IO(3))(2)O(2)](H(2)O) consists of one-dimensional [(UO(2))(2)(IO(3))(2)O(2)](2)(-) ribbons formed from the edge sharing of distorted UO(7) pentagonal bipyramids. In both compounds the iodate groups occur in both bridging and monodentate binding modes and further serve to terminate the edges of the uranium oxide chains. The K(+) or Ba(2+) cations separate the chains or ribbons in these compounds forming bonds with terminal oxygen atoms from the iodate ligands. Crystallographic data: K(2)[(UO(2))(3)(IO(3))(4)O(2)], triclinic, space group P_1, a = 7.0372(5) A, b = 7.7727(5) A, c = 8.9851(6) A, alpha = 93.386(1) degrees, beta = 105.668(1) degrees, gamma = 91.339(1) degrees, Z = 1; Ba[(UO(2))(2)(IO(3))(2)O(2)](H(2)O), monoclinic, space group P2(1)/c, a = 8.062(4) A, b = 6.940(3) A, c = 21.67(1), beta= 98.05(1) degrees, Z = 4.